CareDx Stock News

Equities analysts expect CareDx Inc (NASDAQ:CDNA) to announce ($0.02) earnings per share for the current quarter, according to Zacks. Three analysts have made estimates for CareDx’s earnings, with t

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

SOUTH SAN FRANCISCO, Calif., April 27, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.

Leaders in HLA and transplant laboratory solutions will present at CareDx virtual symposiums originally planned for EFI

Wall Street analysts expect CareDx Inc (NASDAQ:CDNA) to post sales of $38.23 million for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for CareDx’s earnings, w

The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week, with Immunomedics, Inc.'s

CareDx (NASDAQ:CDNA)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Friday, AnalystRatings.com reports. They currently have a $4

Anpac Bio-Medical Science (NASDAQ:ANPC) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of thei

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx (CDNA) today and set a price target of $43.00. The company's shares closed last Thursday

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx ( CDNA – Research Report ) today and set a price target of $43.00 . The company’s shares closed last Thursday at $24.08. According

CareDx is targeting the medically essential stem cell and organ transplant market. The company has a robust financial profile. Investors, however, should be awa

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.